1-Alkenyl-1,1-heterobimetallics are potentially very useful in stereoselective organic synthesis, but are relatively unexplored. Introduced herein is a practical application of 1-alkenyl-1,1-heterobimetallic intermediates in the synthesis of versatile cyclopropyl alcohol boronate esters, which are valuable building blocks. Thus, hydroboration of 1-alkynyl-1-boronate esters with dicyclohexylborane generates 1-alkenyl-1,1-diboro species. In situ transmetalation with dialkylzinc reagents furnishes 1-alkenyl-1,1-borozinc heterobimetallic intermediates. Addition of the more reactive Zn–C bond to aldehydes generates the key B(pin) substituted allylic alkoxide intermediates. An in situ alkoxide directed cyclopropanation proceeds with the formation of two more C–C bonds, affording cyclopropyl alcohol boronate esters with three new stereocenters in 58–89% isolated yields and excellent diastereoselectivities (>15:1 dr). Oxidation of the B–C bond provides trisubstituted α-hydroxycyclopropyl carbinols as single diastereomers in excellent yields (75–93%). Facile pinacol-type rearrangement of the α-hydroxycyclopropyl carbinols provides access to both cis- and trans-2,3-disubstituted cyclobutanones with high stereoselectivity (>17:1 dr in most cases) from a common starting material. This methodology has been applied in the synthesis of quercus lactones A and B.
The diastereoselective addition of lithiated vinyl sulfoxides
to
enantiopure sulfinimines provides direct access to a wide assortment
of allylic sulfinamides in good yields and excellent selectivities.
These adducts are key precursors to differently functionalized cis- and trans-dihydropyrroles. Modulation
of the protecting group on nitrogen prior to cyclization has a significant
impact on the stereochemical outcome, allowing for the selective preparation
of 2,5-cis- or 2,5-trans-3-sulfinyl
disubstituted dihydropyrroles from a common sulfinamide intermediate.
Further research on halocyclization conditions has also yielded a
stereoselective synthesis of trisubstituted vinyl aziridines from
these chiral sulfinamides, simply by changing the halogenating agent.
The addition of enantiopure alpha-metalated vinyl and dienyl sulfoxides to enantiomerically pure N-sulfinimines takes place with high diastereoselectivity primarily directed by the N-sulfinimine sulfur. The resulting allylic amines have been further transformed into highly functionalized 3-sulfinyl and 3-sulfonyl 2,5- cis-dihydropyrroles by reaction with electrophiles.
The highly diastereoselective base-promoted intramolecular cyclization of a variety of enantiopure sulfinyl dienyl amines provides novel sulfinyl tetrahydropyridines that are readily converted to 3-hydroxy tetrahydropyridines via sigmatropic rearrangement. The influence of N- and C- substituents on the process has been studied. Procedures to shorten the sequence such as the tandem cyclization followed by [2,3]-sigmatropic rearrangement, as well as cyclization of the free amine, under Boc- or ArSO- deprotection conditions have been examined. Good to excellent levels of selectivity are generally observed for the reported transformations (dr: 75/25 to >98/2). A novel protocol to access substituted amino dienyl sulfoxides is also reported.
[reactions: see text] Readily available sulfinyl and sulfonyl tetrahydrofuran methanol derivatives have been transformed efficiently into a variety of substituted tetrahydrofuryl alcohols by treatment with (PhSe)2 in the presence of an excess of NaBH4. Alternatively, oxirane cleavage with MgI2 produces the related ketones, amenable to stereocontrolled reduction. This reductive cleavage methodology has been applied to short formal syntheses of trans-Kumausyne and Kumausallene.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.